Logo image
A Genomic Signature Approach to Rescue ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator Biosynthesis and Function
Journal article   Open access   Peer reviewed

A Genomic Signature Approach to Rescue ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator Biosynthesis and Function

Shyam Ramachandran, Samantha R Osterhaus, Philip H Karp, Michael J Welsh and Paul B McCray
American journal of respiratory cell and molecular biology, Vol.51(3), pp.354-362
09/2014
DOI: 10.1165/rcmb.2014-0007OC
PMCID: PMC4189493
PMID: 24669817
url
https://doi.org/10.1165/rcmb.2014-0007OCView
Published (Version of record) Open Access

Abstract

The most common cystic fibrosis (CF) mutation, ΔF508, causes protein misfolding, leading to proteosomal degradation. We recently showed that expression of miR-138 enhances CF transmembrane conductance regulator (CFTR) biogenesis and partially rescues ΔF508-CFTR function in CF airway epithelia. We hypothesized that a genomic signature approach can be used to identify new bioactive small molecules affecting ΔF508-CFTR rescue. The Connectivity Map was used to identify 27 small molecules with potential to restore ΔF508-CFTR function in airway epithelia. The molecules were screened in vitro for efficacy in improving ΔF508-CFTR trafficking, maturation, and chloride current. We identified four small molecules that partially restore ΔF508-CFTR function in primary CF airway epithelia. Of these, pyridostigmine showed cooperativity with corrector compound 18 in improving ΔF508-CFTR function. There are few CF therapies based on new molecular insights. Querying the Connectivity Map with relevant genomic signatures offers a method to identify new candidates for rescuing ΔF508-CFTR function.
corrector compound 18 airway epithelia Original Research cystic fibrosis Connectivity Map small molecule compound

Details

Metrics

Logo image